Alkem Laboratories share news, announcements and annual reports
NSE: ALKEMBSE: 539523Pharmaceuticals & BiotechnologyMid Cap
Alkem Laboratories Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Dec 2015
Last close ₹5,155.00up ₹41.50 (0.81%)BSE ₹5,150.00
Share price at the NSE close on 2 Nov 2026. Previous close ₹5,113.50.
2 Nov: open ₹5,100.00, high ₹5,155.00, low ₹5,044.00
52-week range of traded prices to 2 Nov 2026
₹4,811.00Low, 22 Oct 2026₹5,933.50High, 13 Jan 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹61,636 Cr164th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 28.57
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.46
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.03%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 16.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 16.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.11
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 1,00,190
Alkem Laboratories routine notices
126 filed, newest first. Page 2 of 3.
Sep 2023
8 Sep · Routine
Aug 2023
Jul 2023
15 Jul · Routine
5 Jul · Routine
Jun 2023
May 2023
Mar 2023
Feb 2023
10 Feb · Routine
Jan 2023
5 Jan · Routine
Dec 2022
7 Dec · Routine
Nov 2022
11 Nov · Routine
Oct 2022
7 Oct · Routine
Sep 2022
28 Sep · Routine
Aug 2022
30 Aug · Routine
19 Aug · Routine
5 Aug · Routine
Jul 2022
12 Jul · Routine
Jun 2022
29 Jun · Routine
28 Jun · Routine
May 2022
13 May · Routine
Mar 2022
28 Mar · Routine
Feb 2022
Jan 2022
12 Jan · Routine
Dec 2021
Nov 2021
Sep 2021
Aug 2021
Jul 2021
17 Jul · Routine
7 Jul · Routine
Jun 2021
May 2021
Mar 2021
Feb 2021
23 Feb · Routine
Dec 2020
Nov 2020
28 Nov · Routine
Sep 2020
Aug 2020
Jul 2020
17 Jul · Routine
Jun 2020
Mar 2020
Feb 2020
Dec 2019
Sep 2019